GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75F40124C00057ANEON BRILLIENT, LLC

Overview

Award facts

Net obligations
$144.54K
$144,540of $144.54K potential value
Outlays (paid to date)
$144.54K
$144.54K paid of $144.54K obligated$144,540
Period of performance
May 23, 2024 to May 31, 2025
Ended
Modifications
2
Latest action May 31, 2026
Contract type
Definitive contract
PIID 75F40124C00057

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

DIRECT 8(A) AWARD, STAND-ALONE, LABOR-HOUR (LH) TYPE CONTRACT FOR ADDITIVE MANUFACTURING OF MEDICAL PRODUCTS CORE FACILITY SUPPORT.

Dates and value

Award date
Signed on May 23, 2024
Potential end of performance
Jun 30, 2026
Current value
$144,540Base and exercised options
Potential value (if all options are exercised)
$144,540

Obligations by fiscal year of action

  • FY2026: -$425 (de-obligation)
  • FY2024: $144,965

Total across 2 fiscal years: $144,540

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 31, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationRESTON, VA
UEIMS8HMAY331Q5
CAGE code9CUL5
Business sizeSmall businessSize at award, per the contracting officer
Organization typePartnership
Parent companyANEON BRILLIENT, LLC

Business types and certifications

Minority-ownedSelf-certified small disadvantaged business8(a) joint ventureFor-profit organizationLimited liability companyPartnership or LLP

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; BiologicsProgram activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0002
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Not available for competitionB
Reason not competed
Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
Solicitation procedures
Only one sourceSSS
Set-aside
8(a) sole source8AN
Contract pricing
Labor hoursZ
Offers received
1

Solicitation and notices

Solicitation ID
75F40124R00089(as reported)
Solicitation date
May 7, 2024

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
May 23, 2024Base obligation at award: $144,965
Latest action
May 31, 2026 — CloseoutModification P00002; obligation change -$425; administrative: no change in scope or value
Actions by type
  • Base award1
  • Closeout1
  • Other administrative action1
3 actions recorded, May 23, 2024 to May 31, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$425
Latest action: change in base and all options
-$425

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2024/2024-0600-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression